Compare Consun Pharmaceutical Group Ltd. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROE of 21.94%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 42.92
3
Poor long term growth as Operating profit has grown by an annual rate 20.17% of over the last 5 years
4
Positive results in Jun 25
5
With ROE of 23.09%, it has a Fair valuation with a 2.65 Price to Book Value
6
Consistent Returns over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
9.77%
0%
9.77%
6 Months
-1.39%
0%
-1.39%
1 Year
84.54%
0%
84.54%
2 Years
197.39%
0%
197.39%
3 Years
256.37%
0%
256.37%
4 Years
332.15%
0%
332.15%
5 Years
325.69%
0%
325.69%
Consun Pharmaceutical Group Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
15.43%
EBIT Growth (5y)
20.17%
EBIT to Interest (avg)
42.92
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.88
Sales to Capital Employed (avg)
0.66
Tax Ratio
10.07%
Dividend Payout Ratio
49.91%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
121.96%
ROE (avg)
21.94%
Valuation key factors
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
2.65
EV to EBIT
7.41
EV to EBITDA
7.03
EV to Capital Employed
13.91
EV to Sales
2.41
PEG Ratio
0.69
Dividend Yield
NA
ROCE (Latest)
187.86%
ROE (Latest)
23.09%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
3,217.10
2,862.10
12.40%
Operating Profit (PBDIT) excl Other Income
1,106.90
932.70
18.68%
Interest
27.00
23.50
14.89%
Exceptional Items
0.00
0.00
Consolidate Net Profit
994.60
869.10
14.44%
Operating Profit Margin (Excl OI)
322.70%
295.90%
2.68%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 12.40% vs 5.20% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 14.44% vs 9.31% in Dec 2023
About Consun Pharmaceutical Group Ltd. 
Consun Pharmaceutical Group Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






